W0226
Crystal Stuctures of Streptococcal Superantigens Complexed
with T Cell Receptor β Chains.
Hongmin Li1*, Eric Sundberg2*, Patrick M.
Schlievert3, Klaus Karjalainen4, Roy A.
Mariuzza2. 1Wadsworth Center, New York State Dept. of
Health, Empire State Plaza, PO Box 509, Albany, NY 12201, 2Center for
Advanced Research in Biotechnology, University of Maryland Biotechnology
Institute, 9600 Gudelsky Dr., Rockville, MD 20850, 3Dept. of
Microbiology, University of Minnesota School of Medicine, Minneapolis, MN 55455,
4Basel Institute for Immunology, Grenzacherstrasse 487, Postfach
CH-4005, Basel, Switzerland.
Staphylococcal enterotoxins and streptococcal pyrogenic
exotoxins are typical bacterial superantigens (SAGs) that can simultaneously
bind to major histocompatibility complex (MHC) class II molecules and to T-cell
receptor (TCR), resulting in the stimulation of a large number of T-cells
expressing specific V( elements of the TCR repertoire. Here we report the
crystal structures of streptococcal pyrogenic exotoxin A (SPE-A) complexed with
a 14.3.d TCR β chain and of streptococcal
pyrogenic exotoxin C (SPE-C) complexed with a
Vβ2-bearing β
chain. The SPE-A-β-chain complex is formed in a
mode very similar to those of staphylococcal SAG-TCR (-chain complexes (Fields
et al., 1996; Li et al., 1998), in which the CDR2 and FR3 of TCR
Vβ make majority interactions with SPE-A and
there is no direct contact between SPE-A and Vβ
CDR3. In addition, the CDR1 residues of TCR
Vβ8.2 form hydrogen bonds with the disulfide
loop residues of superantigen SPE-A, which was not seen in other complexes. In
contrast, the binding mode of SPE-C-β-chain
complex is considerably different from the above-mentioned SAG-TCR complexes.
The SPE-C simultaneously interacts with all CDR loops of the
Vβ2-bearing TCR
β chain. Thus, although the SAGs perform similar
biological functions, their binding modes to MHC (Li et al., 2001) and to
TCR vary considerably.
*These two authors share the first authorship.
Fields et al. (1996). Nature 384,
188-192.
Li et al. (1998). Immunity 9,
807-816.
Li et al. (2001). Immunity 14,
93-104.